Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter Post-marketing Clinical Investigation of the SING IMT(TM) System, Model NG SI IMT 3X in Patients With Central Vision Impairment Associated With End-stage Age-related Macular Degeneration

NCT04796545 is registered in ClinicalTrials.gov with VisionCare, Inc. as lead sponsor.

NCT NCT04796545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04796545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter Post-marketing Clinical Investigation of the SING IMT(TM) System, Model NG SI IMT 3X in Patients With Central Vision Impairment Associated With End-stage Age-related Macular Degeneration
Lead sponsor
VisionCare, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 13, 2022
Completion date
December 31, 2028
Enrollment
68 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, amd